MedPath

Molecular Mechanisms of Fibrillin/LTBP Superfamily in Renal Fibrosis and Cardiorenal Syndrome

Recruiting
Conditions
Renal Fibrosis, CKD
Registration Number
NCT05012228
Lead Sponsor
National Taiwan University Hospital
Brief Summary

This project is to understand the LTBP4 expression in human renal fibrotic tissues. The investigators will exam major location of LTBP4 expression and check any similar or discrepancy in renal fibrosis with different etiologies.

Detailed Description

The investigators will obtain the residual renal tissues with different etiologies and check the expression of LTBP4. The location and quantitation of LTBP4 in renal tissues will be checked. It will be great to understand the association between the severity of fibrosis and the expression of LTBP4 and other matrix proteins.

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
30
Inclusion Criteria
  • Abnormal kidney function, proteinuria, hematuria
Read More
Exclusion Criteria
  • N/A
Read More

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Expression of LTBP4 in human renal fibrotic tissue5 years
Expression of biomarkers in human renal fibrotic tissue5 years

Potential markers: eg. ROS-related proteins (8-oxodG, 4-HNE)

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

National Taiwan University Hospital

🇨🇳

Taipei, Taiwan

© Copyright 2025. All Rights Reserved by MedPath